The therapeutic perspective of NAD + precursors in age-related diseases
Your kidneys filter vitamins from your blood
Most of these discontinuations occurred within the first 6 weeks of the study ( n =38/53, 71.7%), coinciding with the dose-escalation period, and were mainly due to GI disorders (survodutide: n =36/48, 75.0%
Abnormalities of the auditory brainstem response in vitiligo
Laboratory tests revealed a low hematocrit and hemoglobin concentration, normochromatic erythrocytes with normal morphology, and mild reticulocytosis
Current clinical consensus reflects the following: Research findings are preliminary and insufficient to guide treatment decisions No regulatory approval exists for using GLP-1s in addiction treatment Early signals do not outweigh the lack of long-term outcome data Instead, clinicians continue to recommend established, evidence-based approaches, including: Behavioral therapies tailored to substance use disorders Medication-assisted treatment when medically indicated Comprehensive psychosocial support and relapse-prevention planning Comprehensive assessment remains a cornerstone of safe and effective care